Predictive Genetic Risk Assessment Trial

Completed

Conditions studied: Colon Cancer, Lung Cancer, Atrial Fibrillation, Diabetes Type 2, Obesity, Breast Cancer, Graves Disease, Osteoarthritis, Celiac Disease, Myocardial Infarction, Prostate Cancer

In brief

This proof-of-principle clinical trial at Mayo Clinic studies how patients and their physicians understand and utilize predictive genetic risk assessment. A critical goal of this clinical trial is to understand how individual patients and their doctors perceive and respond to genetic risk information that is largely uncertain.

Key facts

Study ID

NCT00782366

Run by

Mayo Clinic

People needed

26

Starts

2008-03-01

Expected to finish

2010-01-01

Last updated by the study team

2011-04-27

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• must be established EH patient or physician

You may not qualify if…

• pregnant women
• patient who have already purchased Navigenics Health Compass

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.